Status:

UNKNOWN

Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM)

Lead Sponsor:

Robert S Berman MD

Conditions:

Bacterial Infections

Wounds

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Based on personal experience and the literature it is reasonable expectation that Vancomycin is a viable treatment in a direct contact form to eliminate MRSA from open wounds in order to heal the woun...

Detailed Description

Over a prior preliminary 33 month study I have found negative cultures at the end of one week of treatment and have had microbiological studies establishing the same MIC zones in culture media greater...

Eligibility Criteria

Inclusion

  • MRSA infected open wounds
  • Acute and chronic wounds
  • Type of wounds: venous stasis,diabetic, pressure, post surgical, post traumatic, and spontaneous
  • Infection criteria: Include a positive culture for MRSA
  • Location of ulcers: any place on the body
  • Diagnosis of MRSA: Based on tissue cultures of MRSA
  • Willing and reliable patients
  • Study to include only one ulceration no more than 50 square centimeters
  • The study to include stages two and three ulcerations

Exclusion

  • Non-compliant patients
  • Patient must accept all issues in consent form
  • Non compliance to include failed appointments
  • Wounds greater than 50sq. cm
  • No wounds deeper than soft tissue
  • Ischemic or vascular disease, dermatitis, immune deficiency,or psoriasis
  • Allergy to Vancomycin
  • Post irradiation ulceration
  • Bleeding disorders
  • Skin allergies to adhesives and tape
  • Ulcers related to cancers
  • Multiple wounds
  • Stage 4 ulcerations
  • Patients in any other trial
  • Patients with any other conditions which, in the opinion of the investigator/doctor, would preclude participation in the study.

Key Trial Info

Start Date :

July 15 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 15 2024

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00945152

Start Date

July 15 2011

End Date

December 15 2024

Last Update

July 21 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Robert S Berman MD /661 Maplewood Drive #21

Jupiter, Florida, United States, 33458

Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM) | DecenTrialz